ADARx Pharmaceuticals, Inc. (ADRX) vs uniQure N.V. (QURE)

ADARx Pharmaceuticals, Inc. ADRX 13.20 −0.68%
uniQure N.V. QURE 21.62 +2.90%

ADARx Pharmaceuticals, Inc. and uniQure N.V. are both Biotechnology companies. ADARx Pharmaceuticals, Inc. and uniQure N.V. are of similar size ($1.5B and $1.5B).

Metric	ADRX	QURE	Biotechnology median
P/E	—	n/m	10.60
P/S	—	74.94	9.40
P/B	—	5.13	2.13
Price to free cash flow	—	n/m	25.18
EV/EBITDA	—	n/m	0.66
EV/Sales	—	44.70	9.02
Earnings yield	—	(16.22%)	(32.88%)
Free cash flow yield	—	(12.91%)	(23.13%)

Metric	ADRX	QURE	Biotechnology median
Gross margin	—	93.85%	68.51%
Operating margin	—	(1,001.74%)	0.00%
Net margin	—	(1,154.84%)	0.00%
Free cash flow margin	—	(956.80%)	0.00%
Return on equity	—	(88.99%)	(51.96%)
Return on assets	—	(25.47%)	(46.06%)
Return on invested capital	—	0.00%	0.00%

Metric	ADRX	QURE	Biotechnology median
Revenue growth (TTM)	—	28.04%	6.76%
EPS growth (last fiscal year)	—	29.67%	29.88%
Revenue growth, 5-year CAGR	—	(15.57%)	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ADRX	QURE	Biotechnology median
Debt to equity	—	0.17	0.00
Current ratio	—	11.52	4.97
Net debt to EBITDA	—	3.36	1.01

Metric	ADRX	QURE	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	ADRX	QURE	Biotechnology median
Market cap	1.47b	1.46b	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack